Return to List

Study Summary
No. 2003-0718:.......Brain......Charles A. Conrad......Neuro Oncology
.
Study Summary Title
Study Summary
Number:		2003-0718
Study Title:A Phase I/II, Two-Arm, Multicenter, Dose Escalation Study of Oral AEE788 Administered on a Continuous Once Daily Dosing Schedule in Adult Patients with Recurrent or Relapsing Glioblastoma Multiforme
.
Physician New Patient Referral
Name:Charles A. ConradPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Neuro OncologyReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-2883
Contact us about clinical trials
.
General Information
Disease Group:BrainSupported By:Novartis Pharmaceuticals
Phase of Study:Phase I/Phase IIReturn
Visit:		Cycle 1: days 1, 8, 15, 22 & 28. Cycle 2: days 1, 8, 15 and 22. Cycle 3 and up: Days 1 and 15.
Treatment
Agents:		Biopsy
Collection
Imaging
aee788		Home Care:All of the capsules may be taken at home.
Treatment Loc:outpatient
Estimated
Length of Stay
in Houston:		No hospitalization specific to this study. Pts having surgical resection while on study will not require additional hospitalization outside the standard of care for the procedure.
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:01/21/2004
IRB Review and Approval Date:11/05/2003
Study Type:Therapeutic
Recruitment Status:Closed
Projected Accrual:45
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:Written informed consent obtained prior to any screening procedures.
.
Links
Registration Number:
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center